Dr. Warren is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Dana-Farber Cancer Institute
450 Brookline Ave
Boston, MA 02215
Education & Training
- National Capital ConsortiumFellowship, Pediatric Hematology/Oncology, 1993 - 1997
- Children's National HospitalResidency, Pediatrics, 1990 - 1993
- Tufts University School of MedicineClass of 1990
Certifications & Licensure
- MA State Medical License 2019 - 2026
- MD State Medical License 1993 - 2023
- American Board of Pediatrics Pediatrics
Clinical Trials
- Phase I Study of Marizomib + Panobinostat for Children With DIPG Start of enrollment: 2020 Aug 10
Publications & Presentations
PubMed
- 380 citationsGD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas.Robbie G Majzner, Sneha Ramakrishna, Kristen W Yeom, Shabnum Patel, Harshini Chinnasamy
Nature. 2022-03-01 - 8 citationsCharacterizing the pharmacokinetics of panobinostat in a non-human primate model for the treatment of diffuse intrinsic pontine gliomaLouis Rodgers, Cynthia McCully, Arman Odabas, Rafael Cruz, Cody J. Peer
Cancer Chemotherapy and Pharmacology. 2020-01-01 - 36 citationsProton magnetic resonance spectroscopy predicts survival in children with diffuse intrinsic pontine glioma.Emilie A. Steffen-Smith, Joanna H. Shih, Sean J. Hipp, Robyn Bent, Katherine E. Warren
Journal of Neuro-Oncology. 2011-05-13
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: